Showing results (231-240 of 10,875) with videos related to

Sort By:
Pageof 1,088
Breast Cancer Research and Treatment|November 1, 2011
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first courseHélène Kolesnikov-Gauthier, Laurence Vanlemmens, Marie-Christine Baranzelli, et al.
Breast Cancer Research and Treatment|November 1, 2011
Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological featuresJuliana S Festa-Vasconcellos, Diogo N Piranda, Laura M Amaral, et al.
Breast Cancer Research and Treatment|November 1, 2011
The association between mammographic density measures and aspirin or other NSAID useJennifer Stone, Lisa Willenberg, Carmel Apicella, et al.
Breast Cancer Research and Treatment|November 16, 2011
Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulationKarine Chung, Linda J Hovanessian-Larsen, Debra Hawes, et al.
Breast Cancer Research and Treatment|November 19, 2011
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancerM P H M Jansen, E A Reijm, A M Sieuwerts, et al.
Breast Cancer Research and Treatment|November 25, 2011
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?Shiri Bernholtz, Yael Laitman, Bella Kaufman, et al.
Breast Cancer Research and Treatment|November 26, 2011
Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancerMin Zhang, Ye Xu, Tao Ouyang, et al.
Breast Cancer Research and Treatment|November 24, 2011
Investigation of human JC and BK polyomaviruses in breast carcinomasMohamed Hachana, Khaled Amara, Sonia Ziadi, et al.
Breast Cancer Research and Treatment|December 6, 2011
Melatonin pathway genes and breast cancer risk among Chinese womenSandra L Deming, Wei Lu, Alicia Beeghly-Fadiel, et al.
Breast Cancer Research and Treatment|December 6, 2011
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancerA J Montero, C M Diaz-Montero, Y E Deutsch, et al.
Pageof 1,088